Left ventricular dysfunction (LVD) in post-myocardial infarction (MI) patients is an important
predictor of a poor prognosis. LVD may be asymptomatic in the post-MI patient, but it can …

Heart failure secondary to myocardial infarction (MI) remains a major source of morbidity
and mortality. Long-term outcome after MI can be largely be defined in terms of its impact on …

Over the last 50 years, studies investigating the pathogenesis of left ventricular dysfunction
have resulted in many potential therapeutic targets being identified and novel classes of …

Background: A major advance in understanding the pathophysiology of the heart failure
syndrome has been an understanding of the process of left ventricular (LV) remodeling. After …

Left ventricular (LV) remodeling, which can result from myocardial damage or ventricular
pressure or volume overload, has genomic, cellular, and interstitial components with …

Heart failure is a frequent complication of myocardial infarction. Several factors, such as
recurrent myocardial ischemia, infarct size, ventricular remodeling, stunned myocardium …

Considerable efforts have been made during the past decade to understand better the
pathophysiologic processes involved in LV remodeling and the progression of LV …

An understanding of the process of left ventricular (LV) remodeling has led to greater
knowledge of the pathophysiology of heart failure syndrome. This article examines the …

Myocardial infarction (MI) is a leading cause of heart failure. MI is associated with a 7-to 10-
fold greater risk of developing heart failure compared with a normal population. Left …

Cardiac remodeling remains an important primary therapeutic target in patients with
myocardial infarction (MI) and chronic heart failure. It also has utility as a reliable surrogate …